Ergoteles LLC Astrazeneca PLC Transaction History

Ergoteles LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $2.04 Million - $2.22 Million	-29,224 Reduced 73.21%	10,695 $765,000
Q1 2023 May 10, 2023	BUY	$63.15 - $71.6 $588,621 - $667,383	9,321 Added 30.46%	39,919 $2.77 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $446,419 - $580,073	8,235 Added 36.82%	30,598 $2.07 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $235,302 - $602,458	-4,438 Reduced 16.56%	22,363 $1.23 Million
Q2 2022 Aug 12, 2022	BUY	$59.26 - $71.14 $368,597 - $442,490	6,220 Added 30.22%	26,801 $1.77 Million
Q1 2022 May 13, 2022	BUY	$55.72 - $67.12 $1.15 Million - $1.38 Million	20,581 New	20,581 $1.37 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $215,755 - $254,937	-3,994 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $221,906 - $242,795	3,994 New	3,994 $240,000

1,343

492M

4.99M

3.19M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $233B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.